Unexpected Metabolic Versatility in a Combined Fungal Fomannoxin/Vibralactone Biosynthesis

Daniel Schwenk, Philip Brandt, Robert A. Blanchette, Markus Nett, Dirk Hoffmeister

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


The secondary metabolome of an undescribed stereaceous basidiomycete (BY1) was investigated for bioactive compounds. Along with a known fomannoxin derivative and two known vibralactones, we here describe three new compounds of these natural product families, whose structures were elucidated using 1D and 2D NMR spectroscopy and high-resolution mass spectrometry. The new compound vibralactone S (4) shows a 3,6-substituted oxepin-2(7H)-one ring system, which is unprecedented for the vibralactone/fomannoxin class of compounds. Stable isotope labeling established a biosynthetic route that is dissimilar to the two published cascades of oxepinone formation. Another new compound, the antifungal methyl seco-fomannoxinate (6), features a 2-methylprop-1-enyl ether moiety, which is only rarely observed with natural products. The structure of 6 was confirmed by total synthesis. 13C-labeling experiments revealed that the unusual 2-methylprop-1-enyl ether residue derives from an isoprene unit. The diversity of BY1s combined fomannoxin/vibralactone metabolism is remarkable in that these compound families, although biosynthetically related, usually occur in different organisms.

Original languageEnglish (US)
Pages (from-to)1407-1414
Number of pages8
JournalJournal of Natural Products
Issue number5
StatePublished - May 27 2016

Bibliographical note

Publisher Copyright:
© 2016 The American Chemical Society and American Society of Pharmacognosy.


Dive into the research topics of 'Unexpected Metabolic Versatility in a Combined Fungal Fomannoxin/Vibralactone Biosynthesis'. Together they form a unique fingerprint.

Cite this